Rapamycin inhibits transforming growth factor beta 1 induced myofibroblast differentiation via the phosphorylated- phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts

被引:16
作者
Ko, Dong-Yn [1 ]
Shin, Jae-Min [1 ]
Um, Ji-Young [2 ]
Kang, Byungjin [1 ]
Park, Il-Ho [1 ]
Lee, Heung-Man [1 ,2 ,3 ]
机构
[1] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Guro Hosp, 148 Gurodong Ro, Seoul, South Korea
[2] Korea Univ, Coll Med, Div Brain, Korea Program Biomed Sci 21,Guro Hosp, Seoul, South Korea
[3] Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Guro Hosp, Seoul, South Korea
关键词
EXTRACELLULAR-MATRIX; DISEASE; MTOR; PROLIFERATION; ACCUMULATION; MECHANISMS; OUTCOMES;
D O I
10.2500/ajra.2016.30.4389
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: Rapamycin has antiproliferative and antifibrogenic effects in vitro and in vivo. The purpose of this study was to evaluate the effects of rapamycin on transforming growth factor (TGF) beta 1 induced myofibroblast differentiation (alpha smooth-muscle actin [SMA]), extracellular matrix production, and collagen contraction in nasal polyp-derived fibroblasts (NPDF). The underlying molecular mechanisms of rapamycin were also determined in NPDFs. Methods: NPDFs were grown in culture and transformed into myofibroblasts by using TGF beta 1 (5 mu g/mL). For cytotoxicity evaluation, a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide assay was used. Expression levels of alpha SMA, phosphorylated phosphatidylinositol 3-kinase (PI3K), and phosphorylated mammalian target of rapamycin (mTOR) were determined by using Western blot, reverse transcription-polymerase chain reaction, and immunofluorescence staining. The total amount of collagen was analyzed by using the Sircol collagen assay, and contractile activity was measured with a collagen gel contraction assay. Silencing mTOR with mTOR-specific small interference RNA was determined by using reverse transcription-polymerase chain reaction. Results: Whereas rapamycin (range, 0-400 nM) had no significant cytotoxic effects on TGF beta 1 induced NPDFs, it significantly reduced the expression levels of alpha-SMA in TGF beta 1 induced NPDFs in a dose-dependent manner. TGF beta 1 induced collagen production and collagen contraction were significantly inhibited by rapamycin treatment. Rapamycin also attenuated the TGF beta 1 induced activation of PI3K and mTOR, and its inhibitory effects were similar to those of mTOR silencing and a specific PI3K inhibitor. Conclusions: Rapamycin inhibited TGF beta 1 induced myofibroblast differentiation, extracellular matrix production, and collagen contraction through the PI3K/mTOR signal pathways in NPDFs.
引用
收藏
页码:E211 / E217
页数:7
相关论文
共 28 条
  • [21] Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps
    Wang, QP
    Escudier, E
    RoudotThoraval, F
    AlSamad, IA
    Peynegre, R
    Coste, A
    [J]. LARYNGOSCOPE, 1997, 107 (07) : 926 - 931
  • [22] Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials
    Webster, Angela C.
    Lee, Vincent W. S.
    Chapman, Jeremy R.
    Craig, Jonathan C.
    [J]. TRANSPLANTATION, 2006, 81 (09) : 1234 - 1248
  • [23] Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps
    Xu, Geng
    Xia, Jiahong
    Hua, Xiaoyang
    Zhou, Han
    Yu, Chuanzhao
    Liu, Zheng
    Cai, Kemin
    Shi, Jianbo
    Li, Huabin
    [J]. RESPIRATORY RESEARCH, 2009, 10
  • [24] Expanding mTOR signaling
    Yang, Qian
    Guan, Kun-Liang
    [J]. CELL RESEARCH, 2007, 17 (08) : 666 - 681
  • [25] Two-year clinical outcomes of different drug-eluting stents with different polymer coating strategies in coronary artery heart disease: A multi-centre, randomised, controlled clinical trial
    Zhang, Yue
    Shen, Junle
    Li, Zhifeng
    Zhu, Aidong
    Yuan, Yuelong
    Yue, Ruihua
    Yuan, Jia
    Yin, Yuehui
    She, Qiang
    Chen, Yunqing
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2646 - 2652
  • [26] A Novel Aptamer Targeting TGF-β Receptor II Inhibits Transdifferentiation of Human Tenon's Fibroblasts into Myofibroblast
    Zhu, Xiaoyan
    Li, Lei
    Zou, Lingyun
    Zhu, Xudong
    Xian, Guangjun
    Li, Haijun
    Tan, Yan
    Xie, Lin
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (11) : 6897 - 6903
  • [27] Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model
    Zhu, Y. Q.
    Cui, W. G.
    Cheng, Y. S.
    Chang, J.
    Chen, N. W.
    Yan, L.
    Li, M. H.
    [J]. ENDOSCOPY, 2013, 45 (06) : 458 - 468
  • [28] mTOR: from growth signal integration to cancer, diabetes and ageing
    Zoncu, Roberto
    Efeyan, Alejo
    Sabatini, David M.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (01) : 21 - 35